Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

4.4K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interlaboratory Comparison of Orbitrap Analyzers in OrbiSIMS: Noise Parameters, Intensity Scaling, and Detection Limits.

Journal of the American Society for Mass Spectrometry·2026
Same author

Metalloporphyrin-Based Cathode for Rechargeable Magnesium-Ion Batteries: Copper Leaching and Interphase Formation.

ChemSusChem·2025
Same author

Comparative Evaluation of Biocompatibility Data from the Subcutaneous and the Calvaria Implantation Model of a Novel Bone Substitute Block.

In vivo (Athens, Greece)·2025
Same author

Influence of canstatin on fibroblast-driven hypervascularisation in rheumatoid arthritis.

Annals of the rheumatic diseases·2025
Same author

Correction: Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma.

Journal of hematology & oncology·2025
Same author

Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma.

Journal of hematology & oncology·2024

Related Experiment Video

Updated: Feb 22, 2026

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles
05:50

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles

Published on: June 2, 2023

1.9K

Silver nanoparticles do not alter human osteoclastogenesis but induce cellular uptake.

Linda Pauksch1, Marcus Rohnke2, Reinhard Schnettler1,3

  • 1Laboratory for Experimental Trauma Surgery, Justus-Liebig University Giessen, Schubertstrasse 81, 35392 Giessen, Germany.

Toxicology Reports
|October 1, 2017
PubMed
Summary

Silver nanoparticles show antimicrobial promise for bone infections, but higher concentrations may induce cell stress and oxidative damage in osteoclasts. Further research is needed to balance benefits and risks.

More Related Videos

Methods for Analyzing the Impacts of Natural Uranium on In Vitro Osteoclastogenesis
09:51

Methods for Analyzing the Impacts of Natural Uranium on In Vitro Osteoclastogenesis

Published on: January 30, 2018

8.5K
Using Magnetometry to Monitor Cellular Incorporation and Subsequent Biodegradation of Chemically Synthetized Iron Oxide Nanoparticles
08:13

Using Magnetometry to Monitor Cellular Incorporation and Subsequent Biodegradation of Chemically Synthetized Iron Oxide Nanoparticles

Published on: February 27, 2021

5.1K

Related Experiment Videos

Last Updated: Feb 22, 2026

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles
05:50

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles

Published on: June 2, 2023

1.9K
Methods for Analyzing the Impacts of Natural Uranium on In Vitro Osteoclastogenesis
09:51

Methods for Analyzing the Impacts of Natural Uranium on In Vitro Osteoclastogenesis

Published on: January 30, 2018

8.5K
Using Magnetometry to Monitor Cellular Incorporation and Subsequent Biodegradation of Chemically Synthetized Iron Oxide Nanoparticles
08:13

Using Magnetometry to Monitor Cellular Incorporation and Subsequent Biodegradation of Chemically Synthetized Iron Oxide Nanoparticles

Published on: February 27, 2021

5.1K

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Cell Biology

Background:

  • Periprosthetic infections are increasingly caused by multi-drug resistant bacteria.
  • Silver nanoparticles (nanosilver) offer broad-spectrum antimicrobial efficacy, making them a potential biomaterial additive.
  • Knowledge regarding nanosilver's impact on bone cells is limited.

Purpose of the Study:

  • To investigate the effects of silver nanoparticles on osteoclastogenesis.
  • To evaluate nanosilver's influence on human peripheral blood mononuclear cells differentiating into osteoclasts.

Main Methods:

  • Incubation of human peripheral blood mononuclear cells with subtoxic concentrations of nanosilver.
  • Assessment of osteoclast differentiation and podosomal structures.
  • Analysis of nanoparticle uptake and intracellular localization.
  • Evaluation of oxidative stress markers and endocytosis pathways via mRNA levels.

Main Results:

  • Subtoxic nanosilver concentrations did not alter osteoclast differentiation or podosomal structures.
  • Osteoclasts internalized nanosilver, accumulating it in endo-lysosomal compartments.
  • Nanosilver exposure increased oxidative stress and decreased clathrin-dependent endocytosis at the mRNA level.

Conclusions:

  • Nanosilver can induce cellular stress in osteoclasts at higher concentrations.
  • The antibacterial advantages of nanosilver in biomaterials must be carefully weighed against potential health risks.
  • Further studies are required to fully understand the implications of nanosilver use in bone-related applications.